JSL
RMD icon

JT Stratford LLC’s ResMed RMD Stock Holding History

JT Stratford LLC’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$763K Sell
3,399
-203
-6% -$50.6K 0.1% 175
2025
Q4 		$868K Sell
3,602
-2,728
-43% -$698K 0.11% 161
2025
Q3 		$1.73M Sell
6,330
-2,298
-27% -$628K 0.23% 94
2025
Q2 		$2.23M Sell
8,628
-522
-6% -$125K 0.34% 62
2025
Q1 		$2.05M Sell
9,150
-1,297
-12% -$303K 0.36% 57
2024
Q4 		$2.39M Buy
10,447
+4,491
+75% +$1.08M 0.39% 50
2024
Q3 		$1.45M Buy
5,956
+7
+0.1% +$1.56K 0.25% 96
2024
Q2 		$1.14M Buy
5,949
+824
+16% +$167K 0.21% 119
2024
Q1 		$1.01M Buy
+5,125
New +$939K 0.2% 133

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JT Stratford LLC's RMD Position: Q1 2026 in Review

JT Stratford LLC reduced its ResMed (RMD) stake by 5.6% in Q1 2026, selling an estimated $50.6K and leaving 3,399 shares worth $763K. The position accounts for 0.1% of the portfolio, ranked #175.

JT Stratford LLC first reported a position in RMD in Q1 2024 and has held it in 9 quarters since. The position peaked at $2.39M in Q4 2024. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • JT Stratford LLC held 3,399 shares of ResMed worth $763K as of Q1 2026.
  • JT Stratford LLC sold 203 ResMed shares in Q1 2026, an estimated $50.6K.
  • ResMed made up 0.1% of JT Stratford LLC's portfolio in Q1 2026, its #175 holding.
  • JT Stratford LLC first reported a position in ResMed in Q1 2024 and has held it in 9 quarters since.
  • JT Stratford LLC's ResMed position peaked at $2.39M in Q4 2024.
  • 939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on JT Stratford LLC's 13F filing for Q1 2026, filed 15 May 2026.